RSS

BIOD Biodel Inc.

Last Post: 09/19/16
Followers: 0
Posts Today: 0
Views Today: 123

BIOD Stock Quote & Tools

BIOD Stock Message Board Discussion

Top 10 Most Recent News Articles

Limina’s Amberflo Deal Makes AI Usage Visible at Scale

Updated Category News Views 26

Enterprise AI has created a billing fog, and Limina just bought itself a flashlight. Its merger with Amberflo, completed on October 30 and announced November 19, brings metering, cost attribution, and billing technology fully inside Limina’s data-governance platform. No price was disclosed, which is irritating but ordinary for a transaction involving companies that do...

Continue Reading
Palmer Holland Takes Natural Colors Across North America

Updated Category News Views 0

Natural food color sounds like a tidy little ingredient story until somebody tries to keep a blue beverage blue on a retail shelf. That is where Palmer Holland's new exclusive North American commercial arrangement with BOTANIKind gets interesting. This is not a flashy public-market transaction, and neither company has handed investors a revenue figure, volume target, or...

Continue Reading
Youdao Profit Holds, but Revenue and Cash Raise Flags

Updated Category News Views 51

Profitability Arrived With a Few Splinters A shrinking top line wearing a profit badge is never an easy thing to applaud. Youdao delivered RMB1.4 billion in third-quarter 2026 revenue, or US$213.1 million, down 12.3% from a year earlier. Yet income from operations climbed 19.2% to RMB33.7 million, making this the company’s ninth consecutive quarter of operating...

Continue Reading
Envision’s COP31 Pitch Hinges on Grid Execution, Not Targets

Updated Category News Views 93

A 2,500 GW traffic jam is a rotten place to park climate ambition. Envision Energy used COP31 in Antalya to make the more useful point: clean-power targets mean very little if grids cannot connect, balance and dispatch the electricity. Kane Xu’s message was not another round of flag-waving promises. It was an argument that the constraint has shifted from wanting...

Continue Reading
AbbaDox Finds Follow-Up Scans Lost in the Shuffle

Updated Category News Views 109

A six-month recommendation has a nasty habit of disappearing beneath today’s emergencies. That is the unglamorous, important problem AbbaDox is trying to solve in outpatient radiology: not reading the scan, but making sure a future scan recommendation actually gets reviewed, ordered, and scheduled. For investors watching healthcare operations software, this is the sort...

Continue Reading
Scientific Games Takes Big Buck Hunter to Lotteries

Updated Category News Views 76

A mounted arcade cabinet is an odd place to find lottery growth, yet Scientific Games may be onto something with its exclusive Big Buck Hunter licensing deal. Announced November 19, 2026, the arrangement lets the company carry a 26-year-old arcade franchise into U.S. and Canadian instant scratch games, Fast Play, draw games, digital products and second-chance promotions....

Continue Reading
V2’s FOAS Bets on Candid Ad Sales Operator Dialogue

Updated Category News Views 75

Ad sales rarely gets fixed by another ballroom panel, and V2 seems to know it. Its new Future of Ad Sales, or FOAS, forum is built around a simpler premise: put senior operators in a small room, keep vendors and conference theatrics out of the way, and let people compare the ugly real-world details of running revenue machines. Announced November 19, 2026, FOAS is an...

Continue Reading
Hyundai’s Third SUV Crown Matters Beyond the Trophy

Updated Category News Views 90

A Three-Year Streak Is Not Just Decorative Three straight SUV-brand wins can make even a cynical car watcher pause. Hyundai has been named U.S. News & World Report’s 2027 Best SUV Brand after editors assessed vehicles from 39 brands, and that is a useful bit of outside validation in a segment where nearly everybody is throwing sheet metal, screens, and marketing dollars...

Continue Reading
Cineverse Sets Wolf Creek Return for March 19, 2027

Updated Category News Views 64

A sunburned serial killer is heading back to theaters, and Cineverse has finally put a date on it: March 19, 2027. WOLF CRE3K, formerly called Wolf Creek: Legacy, brings John Jarratt back as Mick Taylor for the third film in the Australian horror franchise. For NASDAQ:CNVS investors, this is not the kind of announcement that lets anyone pencil in revenue with a straight...

Continue Reading
EmTech AI 2027 Puts AI Ambitions Through Reality Test

Updated Category News Views 111

A three-day gathering cannot settle AI's biggest arguments, but MIT Technology Review has picked the right fight for EmTech AI 2027: make the industry face a Reality Test. The conference runs May 11–13, 2027, at MIT's campus and online, and that theme lands because the AI conversation has spent plenty of time admiring the engine while skipping the ugly maintenance bill....

Continue Reading

Top 5 Most Recently Viewed Articles

Globeleq Strengthens Leadership with Alasdair Martin's Appointment

Updated Category News Views 169

Globeleq Welcomes Alasdair Martin as Director of Private Customer Solutions Globeleq, a prominent independent power company in Africa, has appointed Alasdair Martin to the crucial role of Director of Private Customer Solutions. This appointment is a strategic move that aligns with the company's vision for growth through innovation and sustainable energy transformation in...

Continue Reading
Orthofix Medical's Q4 2026 Earnings: Unpacking The Numbers

Updated Category News Views 186

Earnings Breakdown Let's get into the nitty-gritty of Orthofix Medical's earnings for Q4 of 2026. Rollercoaster ride, anyone? They posted an earnings-per-share (EPS) of $0.24, which is a solid beat over the $0.12 consensus estimate. That's a clean 100% overcall—on paper, that's the kind of news that gets you smiling on your way to the bank. Honestly, an earnings double...

Continue Reading
bioAffinity Technologies Achieves Milestone with CyPath® Lung Test

Updated Category News Views 106

bioAffinity Technologies Celebrates Initial Success of CyPath® Lung b>bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), dedicated to advancing noninvasive cancer detection and lung disease diagnostics, has unveiled remarkable outcomes from its recent pilot marketing program for the CyPath® Lung test. Focused on enhancing patient care, the Texas beta launch has seen...

Continue Reading
Hamilton Beach Brands Reports Strong Q3 Performance for 2024

Updated Category News Views 145

Company Overview Hamilton Beach Brands Holding Company (NYSE: HBB) is an established leader in the design, marketing, and distribution of a variety of small electric household appliances and specialty products. With a portfolio that includes well-known consumer brands such as Hamilton Beach® and Proctor Silex®, the company continues its mission to enhance daily living...

Continue Reading
Melexis Expands Treasury Share Holdings with Recent Buyback

Updated Category News Views 155

Melexis Share Buy-Back Program Update Melexis is excited to share an update regarding its ongoing share buy-back program, originally announced several months ago. This initiative aims to enhance shareholder value and stabilize stock prices in today’s dynamic market environment. As part of this program, Melexis has recently engaged in notable share purchases on Euronext...

Continue Reading